Skip to content
Issue price
₹79
Listing price
₹83
+5.06%
Current price
₹105.95
+34.11%
Subscribed
7.27x
Issue size
₹165 Cr
Listed on
27 Feb 2026

IPO timeline

  1. Opens
    20 FebFri
  2. Closes
    24 FebTue
  3. Allotment
    25 FebWed
  4. Refunds
    26 FebThu
  5. Demat credit
    26 FebThu
  6. Listing
    27 FebFri

Issue details

Price band
₹75 – ₹79 per share
Issue size
₹165 Cr
Fresh issue
₹90 Cr · 1.14 Cr shares
Offer for sale
₹75 Cr
Issue type
Fresh capital cum OFS
Face value
₹5 per share
Lot size
189 shares
Minimum investment
₹14,931
Listing on
NSE & BSE
Exchange code
GAUDIUMIVF.BO · 7603
Fresh issue 55% (goes to the company)Offer for sale 45% (goes to selling shareholders)

Lot size and investment

ApplicationLotsSharesAmount
Retail (Min)1189₹14,931
Retail (Max)132,457₹1,94,103
S-HNI (Min)142,646₹2,09,034
B-HNI (Min)6712,663₹10,00,377

Reservation

QIB
1,04,43,100 shares (50.00% of the Offer)
NII
31,32,930 shares (15.00% of the Offer)
Retail
73,10,170 shares (35.00% of the Offer)

Allotment status

Registrar: Bigshare Services Private Limited

The allotment for this IPO is final. Check whether you received shares on the registrar's website using your PAN, application number or demat account (DP / Client ID).

Check allotment on Bigshare Services
  1. 1Open the registrar's allotment page and select this IPO from the list.
  2. 2Enter your PAN, application number or DP / Client ID.
  3. 3Submit to see the number of shares allotted, if any.
Basis of allotment
25 Feb 2026
Refunds initiated
26 Feb 2026
Shares credited to demat
26 Feb 2026
Listing
27 Feb 2026
Basis of allotment document

Grey market premium (GMP)

Updated 27 Feb 2026, 09:19 AM IST
Current GMP
₹-5
-6.00%
Estimated listing price
₹74
Issue price ₹79
Highest
₹15
17 Feb
Lowest
₹-5
26 Feb

GMP by day (₹ per share)

Day-wise GMP table
DateGMPPremiumEst. listing
27 Feb 2026₹-5-6.00%₹74
26 Feb 2026₹-5-6.00%₹74
25 Feb 2026₹-2-3.00%₹77
24 Feb 2026₹4+5.00%₹83
23 Feb 2026₹5+6.00%₹84
22 Feb 2026₹8+10.00%₹87
21 Feb 2026₹8+10.00%₹87
20 Feb 2026₹8+10.00%₹87
19 Feb 2026₹9+11.00%₹88
18 Feb 2026₹12+15.00%₹91
17 Feb 2026₹15+19.00%₹94
16 Feb 2026₹0—₹79
14 Feb 2026₹0—₹79
Kostak rate
₹0

GMP is an unofficial indicator from an unregulated market. It is shown for information only and is not a prediction of the listing price or a recommendation to apply.

Subscription status

Updated 08 Aug 2026, 04:05 PM IST
Overall subscription
7.27x
Fully subscribed · 2,41,091 applications
  • QIB1.62x
  • NII (HNI)14.05x
  • Retail7.6x
CategoryShares offeredShares bid forSubscribed
Qualified Institutional Buyers (QIB)41,77,24067,67,1291.62x
Non-Institutional Investors (NII)31,32,9304,40,17,66714.05x
bNII — bids above ₹10 Lakh20,88,6202,65,46,36012.71x
sNII — bids ₹2 Lakh to ₹10 Lakh10,44,3101,74,71,30616.73x
Retail Individual Investors (RII)73,10,1705,55,57,2927.6x
Total1,46,20,34010,62,89,8727.27x

Financials

Amounts in Rs. Crore
P/E Ratio
22.99
EPS (₹)
3.12
RoCE
39.70
RoNW
41.71
PAT Margin
26.96

Separate pre- and post-issue P/E are not available for this IPO; the P/E shown is as disclosed for the issue.

Period ended30 sep 202531 Mar 2531 Mar 24
Revenue49.7570.9648.15
OPM %
EBITDA18.9528.6319.27
Net Profit12.5119.1310.32
Debt22.5115.6026.00
Assets106.6288.5151.01
CompanyIssue sizeP/ERoNWPAT marginSubscribedListing gain
Gaudium IVF
This IPO
₹165 Cr22.9941.71%26.96%7.27x+5.06%
Hexagon Nutrition
Mainboard · listed 12 Jun 2026
₹138.87 Cr15.3512.12%9.81%53.68x+7.22%
Kronox Lab Sciences
Mainboard · listed 10 Jun 2024
₹130.15 Cr24.4725.66%22.60%117.25x+21.29%
Amanta Healthcare
Mainboard · listed 9 Sep 2025
₹126 Cr46.5910.89%3.86%82.6x+7.14%
Anlon Healthcare
Mainboard · listed 3 Sep 2025
₹121.03 Cr23.5725.51%17.06%7.12x+1.10%
Gujarat Kidney & Super Speciality
Mainboard · listed 30 Dec 2025
₹250.8 Cr61.6236.61%23.61%5.21x+5.26%
Sai Parenteral's
Mainboard · listed 2 Apr 2026
₹409 Cr72.195.09%8.93%1.08x+2.04%

Peers are other recent IPOs from the same industry, closest in issue size. Ratios are as disclosed at the time of each issue. This is not the listed-peer table from the offer document.

IPO objectives

₹70 Cr total

How Gaudium IVF plans to use the money raised, as stated in the offer document.

  1. Funding capital expenditure towards establishment of New IVF Centers of the Company₹50 Cr
  2. Repayment/pre-payment, in full or in part, of certain outstanding loans availed by our Company; and₹20 Cr
  3. General Corporate Purpose

About Gaudium IVF

Gaudium IVF is a rapidly growing fertility care provider in India, focused on offering advanced reproductive treatments with a patient-centric approach. The company was founded by Dr. Manika Khanna, a well-known fertility expert, with the aim of making high-quality infertility treatments accessible and affordable. Since its inception, Gaudium IVF has expanded its footprint across multiple cities, building a strong reputation for ethical practices, transparent processes, and high success rates. The organisation combines medical expertise with modern infrastructure to address a wide range of fertility challenges faced by couples. The company offers a comprehensive suite of services including IVF (in-vitro fertilisation), IUI (intrauterine insemination), ICSI, egg freezing, fertility preservation, and advanced diagnostic solutions. Its business model is primarily clinic-based, generating revenue through treatment cycles, consultations, and specialised procedures. Gaudium IVF focuses on personalised treatment plans, leveraging technology and experienced medical professionals to improve outcomes. By maintaining quality standards and expanding through new centres and partnerships, the company aims to strengthen its presence in India’s growing fertility services market while ensuring consistent patient care and long-term trust.

Promoters and shareholding

The Promoters of the company are Dr. Manika Khanna, Dr. Peeyush Khanna and Vishad Khanna.

Shares outstanding, pre-issue
6,13,94,384
Shares outstanding, post-issue
7,27,86,884

Anchor investors

4 investors · ₹49.5 Cr raised
InvestorShares allottedAmount% of anchor book
MERU INVESTMENT FUND PCC-CELL 121,51,330₹17 Cr34.33%
SANSHI FUND-I15,82,308₹12.5 Cr25.25%
HORNBILL ORCHID INDIA FUND12,66,300₹10 Cr20.21%
CARNELIAN INDIA MULTI STRATEGY FUND12,65,922₹10 Cr20.2%

Registrar, lead managers and documents

Registrar

Bigshare Services Private Limited

91-22-6263 8200

ipo@bigshareonline.com

Company contact

Gaudium IVF & Women Health Ltd. Address B1/51, Janak Puri, B-1, New Delhi, New Delhi, 110058

011-4885 8585

compliance@gaudiumivfcentre.com

Gaudium IVF IPO: common questions

1.When does the Gaudium IVF IPO open and close?

The Gaudium IVF IPO opens on 20 Feb 2026 and closes on 24 Feb 2026.

2.What is the price band of the Gaudium IVF IPO?

The price band is ₹75 – ₹79 per share, with a lot size of 189 shares and a minimum investment of ₹14,931.

3.What is the size of the Gaudium IVF IPO?

The issue size is ₹165 Cr (Fresh capital cum OFS).

4.What is the GMP of the Gaudium IVF IPO?

The last reported grey market premium is ₹-5 per share as of 27 Feb 2026, 09:19 AM IST. GMP is unofficial and changes frequently.

5.When is the Gaudium IVF IPO allotment?

The basis of allotment is expected on 25 Feb 2026. Allotment status can be checked with the registrar, Bigshare Services Private Limited.

6.When will the Gaudium IVF IPO list?

The shares listed on 27 Feb 2026 on NSE & BSE.

7.Who is the lead manager of the Gaudium IVF IPO?

The book running lead manager is Sarthi Capital Advisors Pvt.Ltd., and the registrar is Bigshare Services Private Limited.

8.What will the money raised in the Gaudium IVF IPO be used for?

As stated in the offer document, the proceeds are for: Funding capital expenditure towards establishment of New IVF Centers of the Company; Repayment/pre-payment, in full or in part, of certain outstanding loans availed by our Company; and; General Corporate Purpose.

9.How can my company launch an IPO like Gaudium IVF?

Start with an IPO readiness assessment: eligibility for the Main Board, audited financials, governance, conversion to a public limited company and an indicative valuation. Be IPO Ready advises promoters through each step, from readiness to listing day.

For business owners

Your company could be the next listing

Businesses like these raise growth capital on the public markets every week. Tell us about yours and our advisors will tell you, plainly, whether an IPO is within reach and what it would take.

  • Eligibility check against NSE Emerge, BSE SME and Main Board norms
  • Indicative valuation and issue size for your business
  • A clear timeline from readiness to listing day

Check if your business can list

Fill in the eligibility form and get an assessment of where you stand. It takes about five minutes.

Prefer to talk? Call +91 92130 20393